Adaptimmune
Home
Our Company
Overview
arrow_forward
Board of Directors
arrow_forward
Leadership Team
arrow_forward
Products
Pipeline
Overview
arrow_forward
Afami-cel
arrow_forward
Lete-cel
arrow_forward
Uza-cel
arrow_forward
Technology
Overview
arrow_forward
Manufacturing
arrow_forward
Publications
arrow_forward
Patients & Families
Overview
arrow_forward
Taking Part in Our Clinical Trials
arrow_forward
Videos
arrow_forward
Clinical Trials
Overview
arrow_forward
Expanded Access Policy
arrow_forward
Investors & Media
Overview
arrow_forward
News Center
arrow_forward
Financial Info and Governance
arrow_forward
Stock Data
arrow_forward
SEC Filings
arrow_forward
Contact
Careers
Overview
arrow_forward
US Careers
arrow_forward
UK Careers
arrow_forward
Search
Videos
Patients & Families
Patients & Families
Overview
Taking Part in Our Clinical Trials
Videos
SPEARHEAD-2 trial design: combining SPEAR T-cells with pembrolizumab
ADP-A2M4CD8 Mechanism of Action (Next-generation SPEAR T-cell)
How Our SPEAR T-Cells Work
How Cancer Patients get Treated with our SPEAR T-Cells
Cómo funcionan nuestras células SPEAR T
Viaje de un paciente tratado con nuestras células SPEAR T
Comment nos cellules SPEAR T fonctionnent
Le parcours du patient
Mecanismo de Acción del ADP-A2M4CD8 (SPEAR-T cell de próxima generación)
